|
⚲
|
| Keyboard |
| Duey Marc
✚
|
|
|---|---|
| CIK # | 0001925150 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001925150] | |
| 4 | [0001925150] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Duey Marc | |
| Aprea Therapeutics Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Aprea Therapeutics Inc APRE
Common Stock
|
2025-12-10 | Buy | 21,459 | $1.17 | 25,107 |
|
Aprea Therapeutics Inc APRE
Common Warrant · derivative
|
2025-12-10 | Buy | 21,459 | ||
|
Aprea Therapeutics Inc APRE
Stock Options (Right to Buy) · derivative
|
2025-06-05 | Grant | 4,185 | $0.00 | |
|
Aprea Therapeutics Inc APRE
Common Stock
|
2025-06-05 | Grant | 1,045 | $0.00 | |
|
Aprea Therapeutics Inc APRE
Common Stock
|
2024-10-18 | Sell | 6,462 | $4.58 | 29,596 |
|
Aprea Therapeutics Inc APRE
Common Stock
|
2024-10-16 | Buy | 30,000 | $4.39 | 131,700 |
|
Aprea Therapeutics Inc APRE
Common Stock
|
2024-10-14 | Buy | 190 | $2.58 | 490 |
|
Aprea Therapeutics Inc APRE
Common Stock
|
2024-06-20 | Grant | 1,045 | $0.00 | |
|
Aprea Therapeutics Inc APRE
Stock Options (Right to Buy) · derivative
|
2024-06-20 | Grant | 4,185 | $0.00 | |
|
Aprea Therapeutics Inc APRE
Stock Options (Right to Buy) · derivative
|
2023-08-23 | Grant | 2,000 | $0.00 | |
|
Aprea Therapeutics Inc APRE
Common Stock
|
2023-08-23 | Grant | 500 | $0.00 | |
|
Aprea Therapeutics Inc APRE
Common Stock
|
2022-08-23 | Conversion | 11,610 | $0.00 | |
|
Aprea Therapeutics Inc APRE
Series A Non-Voting Convertible Preferred Stock · derivative
|
2022-08-23 | Conversion | 1,161 | $0.00 | |
|
Aprea Therapeutics Inc APRE
Series A Non-Voting Convertible Preferred Stock · derivative
|
2022-08-23 | Conversion | 400,969 | $0.00 | |
|
Aprea Therapeutics Inc APRE
Common Stock
|
2022-08-23 | Conversion | 4,009,690 | $0.00 | |
|
Aprea Therapeutics Inc APRE
Common Stock
|
2022-07-28 | Grant | 5,995 | $0.00 | |
|
Aprea Therapeutics Inc APRE
Stock Option (right to Buy) · derivative
|
2022-07-28 | Grant | 29,575 | $0.00 |